Premature Labor (Tocolysis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Premature labor pipeline market research report provides a comprehensive overview on the therapeutics under development for Premature labor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Premature labor and features dormant and discontinued projects.
Key Targets in the Premature Labor Pipeline Drugs Market
In the Preterm labor pipeline drugs market the key targets are Progesterone Receptor, Oxytocin Receptor, Programmed Cell Death Protein 1, and Prostaglandin F2 Alpha Receptor.
Premature Labor Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Premature Labor Pipeline Drugs Market
Progesterone Receptor Agonist has the highest number of pipeline products followed by Oxytocin Receptor Antagonist, Programmed Cell Death Protein 1 Antagonist, and Prostaglandin F2 Alpha Receptor Antagonist.
Premature Labor Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Premature Labor Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Preterm labor pipeline drugs market are oral, intravenous, vaginal, and intraperitoneal. Oral has the maximum number of pipeline products.
Premature Labor Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Premature Labor Pipeline Drugs Market
The key molecule types in the Premature labor pipeline drugs market are Small Molecule, Biologic, and Protein.
Premature Labor Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Premature Labor Pipeline Drugs Market
The major companies in the Preterm labor pipeline drugs market are Dare Bioscience Inc, Egret Therapeutics Inc, GlaxoSmithKline Plc, ILIAS Biologics Inc, Lipocine Inc, Organon & Co, Osel Inc, Seed Health Inc, and Shenzhen Evergreen Therapeutics Co Ltd.
Premature Labor Pipeline Drugs Market Overview
Key Targets | Progesterone Receptor, Oxytocin Receptor, Programmed Cell Death Protein 1, and Prostaglandin F2 Alpha Receptor |
Key Mechanisms of action | Progesterone Receptor Agonist, Oxytocin Receptor Antagonist, Programmed Cell Death Protein 1 Antagonist, and Prostaglandin F2 Alpha Receptor Antagonist |
Key Routes of Administration | Oral, Intravenous, Vaginal, and Intraperitoneal |
Key molecule types | Small Molecule, Biologic, and Protein |
Major companies | Dare Bioscience Inc, Egret Therapeutics Inc, GlaxoSmithKline Plc, ILIAS Biologics Inc, Lipocine Inc, Organon & Co, Osel Inc, Seed Health Inc, and Shenzhen Evergreen Therapeutics Co Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Premature labor
- The pipeline guide reviews pipeline therapeutics for Premature labor by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Premature labor therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Premature labor therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Premature labor
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective countercstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Premature labor
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Premature labor pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Egret Therapeutics Inc
GlaxoSmithKline Plc
ILIAS Biologics Inc
Lipocine Inc
Organon & Co
Osel Inc
Seed Health Inc
Shenzhen Evergreen Therapeutics Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Premature labor pipeline drugs market?
In the Premature labor pipeline drugs market the key targets are Progesterone Receptor, Oxytocin Receptor, Programmed Cell Death Protein 1, and Prostaglandin F2 Alpha Receptor.
-
What are the key mechanisms of action in the Premature labor pipeline drugs market?
In the Premature labor pipeline drugs market the key mechanisms of action are Progesterone Receptor Agonist, Oxytocin Receptor Antagonist, Programmed Cell Death Protein 1 Antagonist, and Prostaglandin F2 Alpha Receptor Antagonist.
-
What are the key routes of administration in the Premature labor pipeline drugs market?
The key routes of administration in the Premature labor pipeline drugs market are Oral, Intravenous, Vaginal, and Intraperitoneal.
-
What are the key molecule types in the Premature labor pipeline drugs market?
The key molecule types in the Premature labor pipeline drugs market are Small Molecule, Biologic, and Protein.
-
What are the major companies in the Premature labor pipeline drugs market?
In the Premature labor pipeline drugs market the major companies are Dare Bioscience Inc, Egret Therapeutics Inc, GlaxoSmithKline Plc, ILIAS Biologics Inc, Lipocine Inc, Organon & Co, Osel Inc, Seed Health Inc, and Shenzhen Evergreen Therapeutics Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.